Digest Network Come funziona
Network
/
Società
Dy
Non verificato

Dyno Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaEventiIndustriaSaluteTecnica

12 comunicati stampa

Guarda tutti i comunicati
13/05/2026
Eventi
Industria
Scienza
Biotecnologia
Salute
Farmaceutica
Sanità
Dyno Therapeutics Announces Expanded Frontiers Network and Second Annual Genetic Agency Technology Conference (GATC)
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
13/05/2026
Industria
Salute
Tecnica
Biotecnologia
Sanità
Dyno Therapeutics Launches Two New AAV Capsids and AI Platform for Rare Disease Therapeutic Development at the 2026 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
27/04/2026
Eventi
Salute
Tecnica
Biotecnologia
Farmaceutica
Dyno Therapeutics to Present New Capsids and AI Advancements in Gene Delivery at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
08/04/2026
Mercato del lavoro
Industria
Salute
Tecnica
Biotecnologia
Dyno Therapeutics Announces Capsid License Exercised by Astellas for Skeletal Muscle-Targeted Gene Delivery, Validating AI-Powered Technology for Biological Sequence Design
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
18/03/2026
Eventi
Fiere
Information Technology
Biotecnologia
Tecnica
Salute
Sanità
Farmaceutica
Scienza
Software
Dyno Therapeutics Launches Dyno Psi-Phi, an Agentic AI Suite for Protein Binder Design, at NVIDIA GTC 2026
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
12/01/2026
Tecnica
Scienza
Biotecnologia
Salute
Farmaceutica
Industria
Dyno Therapeutics Launches Dyno-yp2, a Top-Performing TfR1-Mediated AAV Capsid, to Further Diversify CNS Delivery Portfolio
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
11/11/2025
Tecnica
Scienza
Biotecnologia
Medicina - Varie
Salute
Eventi
Industria
Dyno Therapeutics Unveils Best-in-Class Dyno-bn8 AAV Vector for Muscle Gene Therapies, Achieving Therapeutic Delivery With Improved Safety Potential
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
11/11/2025
Mercato del lavoro
Eventi
Industria
Scienza
Biotecnologia
Medicina - Varie
Salute
Farmaceutica
Dyno Therapeutics and Trisk Bio Announce Strategic Manufacturing Partnership Through Expanded Frontiers Program
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
14/05/2025
Eventi
Industria
Salute
Tecnica
Biotecnologia
Dyno Therapeutics Announces Inaugural 2025 Genetic Agency Technology Conference and Launch of Dyno Frontiers Program to Accelerate Progress in Patient-Empowering Gene Therapies
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0
14/05/2025
Eventi
Industria
Biotecnologia
Salute
Dyno Therapeutics Launches Three Breakthrough Capsid Delivery Vectors for Next-Generation Eye, Muscle and CNS Gene Therapies at the 2025 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Fonte
Dyno Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0